Progesterone/RANKL is a major regulatory axis in the human breast

Science Translational Medicine

Volumn 5, Issue 182, 2013, Pages

  Tanos, Tamara ^a   Sflomos, George ^a   Echeverria, Pablo C ^b   Ayyanan, Ayyakkannu ^a   Gutierrez, Maria ^a   Delaloye, Jean Francois ^c   Raffoul, Wassim ^c   Fiche, Maryse ^c   Dougall, William ^d   Schneider, Pascal ^e   Yalcin Ozuysal, Ozden ^f   Brisken, Cathrin ^a  

^a EPFL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d AMGEN INC   (United States)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

^f IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; PROGESTERONE; PROGESTERONE RECEPTOR; RNA;

ARTICLE; BREAST; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER PREVENTION; CANCER THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; RNA STABILITY; SIGNAL TRANSDUCTION;

BREAST; FEMALE; HUMANS; PROGESTERONE; RANK LIGAND; RECEPTORS, PROGESTERONE;

EID: 84877748040     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005654     Document Type: Article

References (41)

1. V. Beral; Million Women Study Collaborators, Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362, 419-427 (2003).
2. C. Brisken, B. O'Malley, Hormone action in the mammary gland. Cold Spring Harb. Perspect. Biol. 2, a003178 (2010).
3. L. Ciarloni, S. Mallepell, C. Brisken, Amphiregulin is an essential mediator of estrogen receptor a function in mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 104, 5455-5460 (2007).
4. S. Mallepell, A. Krust, P. Chambon, C. Brisken, Paracrine signaling through the epithelial estrogen receptor a is required for proliferation and morphogenesis in the mammary gland. Proc. Natl. Acad. Sci. U.S.A. 103, 2196-2201 (2006).
5. C. Brisken, S. Park, T. Vass, J. P. Lydon, B. W. O'Malley, R. A. Weinberg, A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 95, 5076-5081 (1998).
6. D. L. Lacey, E. Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y. X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, W. J. Boyle, Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176 (1998).
7. J. E. Fata, Y. Y. Kong, J. Li, T. Sasaki, J. Irie-Sasaki, R. A. Moorehead, R. Elliott, S. Scully, E. B. Voura, D. L. Lacey, W. J. Boyle, R. Khokha, J. M. Penninger, The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103, 41-50 (2000).
8. M. Beleut, R. D. Rajaram,M. Caikovski, A. Ayyanan, D. Germano, Y. Choi, P. Schneider, C. Brisken, Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc. Natl. Acad. Sci. U.S.A. 107, 2989-2994 (2010).
9. A. Mukherjee, S. M. Soyal, J. Li, Y. Ying, B. He, F. J. DeMayo, J. P. Lydon, Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. FASEB J. 24, 4408-4419 (2010).
10. M. L. Asselin-Labat, F. Vaillant, J. M. Sheridan, B. Pal, D. Wu, E. R. Simpson, H. Yasuda, G. K. Smyth, T. J. Martin, G. J. Lindeman, J. E. Visvader, Control of mammary stem cell function by steroid hormone signalling. Nature 465, 798-802 (2010).
11. P. A. Joshi, H. W. Jackson, A. G. Beristain, M. A. Di Grappa, P. A. Mote, C. L. Clarke, J. Stingl, P. D. Waterhouse, R. Khokha, Progesterone induces adult mammary stem cell expansion. Nature 465, 803-807 (2010).
12. M. Shackleton, F. Vaillant, K. J. Simpson, J. Stingl, G. K. Smyth, M. L. Asselin-Labat, L. Wu, G. J. Lindeman, J. E. Visvader, Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88 (2006).
13. J. Stingl, P. Eirew, I. Ricketson, M. Shackleton, F. Vaillant, D. Choi, H. I. Li, C. J. Eaves, Purification and unique properties of mammary epithelial stem cells. Nature 439, 993-997 (2006).
14. A. Van Keymeulen, A. S. Rocha, M. Ousset, B. Beck, G. Bouvencourt, J. Rock, N. Sharma, S. Dekoninck, C. Blanpain, Distinct stem cells contribute to mammary gland development and maintenance. Nature 479, 189-193 (2011).
15. R. van Amerongen, A. N. Bowman, R. Nusse, Developmental stage and time dictate the fate of Wnt/b-catenin-responsive stem cells in the mammary gland. Cell Stem Cell 11, 387-400 (2012).
16. E. Gonzalez-Suarez, A. P. Jacob, J. Jones, R. Miller, M. P. Roudier-Meyer, R. Erwert, J. Pinkas, D. Branstetter, W. C. Dougall, RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 468, 103-107 (2010).
17. D. Schramek, A. Leibbrandt, V. Sigl, L. Kenner, J. A. Pospisilik, H. J. Lee, R. Hanada, P. A. Joshi, A. Aliprantis, L. Glimcher, M. Pasparakis, R. Khokha, C. J. Ormandy, M. Widschwendter, G. Schett, J. M. Penninger, Osteoclast differentiation factor RANKL controls development of progestindriven mammary cancer. Nature 468, 98-102 (2010).
18. W. Tan, W. Zhang, A. Strasner, S. Grivennikov, J. Q. Cheng, R. M. Hoffman, M. Karin, Tumourinfiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature 470, 548-553 (2011).
19. T. Tanos, L. J. Rojo, P. Echeverria, C. Brisken, ER and PR signaling nodes during mammary gland development. Breast Cancer Res. 14, 210 (2012).
20. R. Fernandez-Valdivia, A. Mukherjee, C. J. Creighton, A. C. Buser, F. J. DeMayo, D. P. Edwards, J. P. Lydon, Transcriptional response of the murine mammary gland to acute progesterone exposure. Endocrinology 149, 6236-6250 (2008).
21. C. D. Roskelley, P. Y. Desprez, M. J. Bissell, Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. U.S.A. 91, 12378-12382 (1994).
22. L. Kass, J. T. Erler, M. Dembo, V. M. Weaver, Mammary epithelial cell: Influence of extracellular matrix composition and organization during development and tumorigenesis. Int. J. Biochem. Cell Biol. 39, 1987-1994 (2007).
23. J.D. Graham, P. A. Mote, U. Salagame, J.H. van Dijk, R. L. Balleine, L. I. Huschtscha, R. R. Reddel, C. L. Clarke, DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology 150, 3318-3326 (2009).
24. R. D. Rajaram, C. Brisken, Paracrine signaling by progesterone. Mol. Cell. Endocrinol. 357, 80-90 (2012).
25. A. Ayyanan, O. Laribi, S. Schuepbach-Mallepell, C. Schrick, M. Gutierrez, T. Tanos, G. Lefebvre, J. Rougemont, O. Yalcin-Ozuysal, C. Brisken, Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. Mol. Endocrinol. 25, 1915-1923 (2011).
26. E. M. McGowan, N. Alling, E. A. Jackson, D. Yagoub, N. K. Haass, J. D. Allen, R. Martinello-Wilks, Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: Pitfalls of the MTS assay. PLoS One 6, e20623 (2011).
27. R. B. Clarke, A. Howell, C. S. Potten, E. Anderson, Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57, 4987-4991 (1997).
28. M. E. Smoot, K. Ono, J. Ruscheinski, P. L. Wang, T. Ideker, Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics 27, 431-432 (2011).
29. P. C. Echeverría, F. Forafonov, D. P. Pandey, G. Mühlebach, D. Picard, Detection of changes in gene regulatory patterns, elicited by perturbations of the Hsp90 molecular chaperone complex, by visualizing multiple experiments with an animation. BioData Min. 4, 15 (2011).
30. E. Bachelard-Cascales, M. Chapellier, E. Delay, G. Pochon, T. Voeltzel, A. Puisieux, C. Caron de Fromentel, V. Maguer-Satta, The CD10 enzyme is a key player to identify and regulate human mammary stem cells. Stem Cells 28, 1081-1088 (2010).
31. C. Brisken, A. Heineman, T. Chavarria, B. Elenbaas, J. Tan, S. K. Dey, J. A. McMahon, A. P. McMahon, R. A. Weinberg, Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 14, 650-654 (2000).
32. J. R. Masters, J. O. Drife, J. J. Scarisbrick, Cyclic variation of DNA synthesis in human breast epithelium. J. Natl. Cancer Inst. 58, 1263-1265 (1977).
33. B. Mulac-Jericevic, J. P. Lydon, F. J. DeMayo, O. M. Conneely, Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. U.S.A. 100, 9744-9749 (2003).
34. C. S. Ross-Innes, R. Stark, A. E. Teschendorff, K. A. Holmes, H. R. Ali, M. J. Dunning, G. D. Brown, O. Gojis, I. O. Ellis, A. R. Green, S. Ali, S. F. Chin, C. Palmieri, C. Caldas, J. S. Carroll, Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389-393 (2012).
35. C. Curtis, S. P. Shah, S. F. Chin, G. Turashvili, O. M. Rueda, M. J. Dunning, D. Speed, A. G. Lynch, S. Samarajiwa, Y. Yuan, S. Gräf, G. Ha, G. Haffari, A. Bashashati, R. Russell, S. McKinney; METABRIC Group, A. Langerød, A. Green, E. Provenzano, G. Wishart, S. Pinder, P. Watson, F. Markowetz, L. Murphy, I. Ellis, A. Purushotham, A. L. Børresen-Dale, J. D. Brenton, S. Tavaré, C. Caldas, S. Aparicio, The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346-352 (2012).
36. M. Hartman, K. Czene, M. Reilly, J. Bergh, P. Lagiou, D. Trichopoulos, H. O. Adami, P. Hall, Genetic implications of bilateral breast cancer: A population based cohort study. Lancet Oncol. 6, 377-382 (2005).
37. G. L. Anderson, R. T. Chlebowski, A. K. Aragaki, L. H. Kuller, J. E. Manson, M. Gass, E. Bluhm, S. Connelly, F. A. Hubbell, D. Lane, L. Martin, J. Ockene, T. Rohan, R. Schenken, J. Wactawski- Wende, Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: Extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncol. 13, 476-486 (2012).
38. T. K. Said, O. M. Conneely, D. Medina, B. W. O'Malley, J. P. Lydon, Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo. Endocrinology 138, 3933-3939 (1997).
39. S. Giulianelli, J. P. Vaqué, R. Soldati, V. Wargon, S. I. Vanzulli, R. Martins, E. Zeitlin, A. A. Molinolo, L. A. Helguero, C. A. Lamb, J. S. Gutkind, C. Lanari, Estrogen receptor alpha mediates progestininduced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters. Cancer Res. 72, 2416-2427 (2012).
40. L. K. Swee, K. Ingold-Salamin, A. Tardivel, L. Willen, O. Gaide, M. Favre, S. Demotz, M. Mikkola, P. Schneider, Biological activity of ectodysplasin A is conditioned by its collagen and heparan sulfate proteoglycan-binding domains. J. Biol. Chem. 284, 27567-27576 (2009).
41. P. Schneider, Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins. Methods Enzymol. 322, 325-345 (2000).